未登录

S

Sun, Bingjun

Shenyang Pharmaceutical University

H指数:0

被引数:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment

JOURNAL OF CONTROLLED RELEASE

IF11.5

2024-11-010

PRE

Sodium cholesterol sulfate mediated mitoxantrone prodrug electrostatic nanocomplexes: achieving the therapeutic efficacy and safety of mitoxantrone

SCIENCE CHINA-CHEMISTRY

IF9.7

2024-10-210

PRE

Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy

二元前药纳米组件结合化疗和ferroptosis激活可有效治疗三阴性乳腺癌

CHINESE CHEMICAL LETTERS

IF8.9

2024-10-015

PRE

Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety

JOURNAL OF CONTROLLED RELEASE

IF11.5

2023-08-018

PRE

Lymph node-targeting nanovaccines for cancer immunotherapy

靶向淋巴结的纳米疫苗用于癌症免疫治疗

JOURNAL OF CONTROLLED RELEASE

IF11.5

2022-11-0137

PRE

Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF11.9

2022-03-0121

OA

Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy

用于增强化学免疫疗法的基于紫杉醇衍生物的脂质体纳米平台

JOURNAL OF CONTROLLED RELEASE

IF11.5

2022-01-0134

PRE

Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF11.9

2021-11-0134

OAAI

Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photothermal cancer therapy

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2021-09-2027

OAAI

Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF11.9

2021-09-0121

OAAI

Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF11.9

2021-05-0147

OAAI

Dimeric prodrug-based nanomedicines for cancer therapy

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-10-0185

PREAI

Ferroptosis-driven nanotherapeutics for cancer treatment

铁死亡驱动的纳米疗法用于癌症治疗

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-03-01158

PREAI

Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF11.9

2019-09-0120

OAAI

Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy

用于协同化学光动力疗法的异型二聚体的自促进ROS响应纳米组装

JOURNAL OF CONTROLLED RELEASE

IF11.5

2019-05-01126

PREAI

Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer

JOURNAL OF CONTROLLED RELEASE

IF11.5

2018-09-0140

PREAI

Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy

JOURNAL OF CONTROLLED RELEASE

IF11.5

2017-10-01124

PREAI